Crossmark

Utility of Bayesian Single-Arm Design in New Drug Application for Rare Cancers in Japan: A Case Study of Phase 2 Trial for Sarcoma

Published Online: 2018-12-30

Published Print: 2018-05

Authors

Hirakawa, Akihiro

Nishikawa, Tadaaki

Yonemori, Kan

Shibata, Taro

Nakamura, Kenichi

Ando, Masashi

Ueda, Takafumi

Ozaki, Toshifumi

Tamura, Kenji

Kawai, Akira

Fujiwara, Yasuhiro
Funding

Funding for this research was provided by:

Japan Agency for Medical Research and Development (17lk0201044h0002)
License Information

Text and Data Mining valid from 2018-05-01
More Information

Article History

Received: 29 May 2017

Accepted: 7 August 2017

First Online: 30 December 2018

Document is current